Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples